Filana Therapeutics, Inc. Receivables, Net, Current
Filana Therapeutics, Inc. (FLNA) had Receivables, Net, Current of $231.00 thousand as of 2011-09-30, per its 10-Q filed 2011-11-03.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:ReceivablesNetCurrent · last filed 2012-02-09
- 2011-09-30: Receivables, Net, Current $231.00K.
- 2011-06-30: Receivables, Net, Current $908.00K.
- 2010-12-31: Receivables, Net, Current $7.11M.
| Period end | Receivables, Net, Current |
|---|---|
| 2011-09-30 | $231.00K 10-Q · filed 2011-11-03 |
| 2011-06-30 | $908.00K 10-Q · filed 2011-08-04 |
| 2010-12-31 | $7.11M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |